Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bridget Martinez

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Neural Regeneration Research|May 10, 2022
MicroRNAs as biomarkers in glaucoma and potential therapeutic targetsBridget Martinez, Philip V Peplow
Neural Regeneration Research|February 27, 2019
Amelioration of Alzheimer's disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer's diseaseBridget Martinez, Philip V Peplow
Neural Regeneration Research|March 3, 2017
Blood microRNAs as potential diagnostic markers for hemorrhagic strokeBridget Martinez, Philip V Peplow
Physiology (Bethesda, Md.)|February 17, 2017
Thyroid Hormone Regulation and Insulin Resistance: Insights From Animals Naturally Adapted to FastingBridget Martinez, Rudy M Ortiz
Neural Regeneration Research|September 2, 2021
MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approachesBridget Martinez, Philip V Peplow
Neural Regeneration Research|August 6, 2024
MicroRNAs as potential diagnostic biomarkers for bipolar disorderBridget Martinez, Philip V Peplow
Neural Regeneration Research|March 4, 2026
Exosomes and microRNAs in the treatment of in vivo and in vitro models of Parkinson's disease: A narrative literature reviewBridget Martinez, Philip V Peplow
Neural Regeneration Research|August 2, 2017
Immunomodulators and microRNAs as neurorestorative therapy for ischemic strokeBridget Martinez, Philip V Peplow
Neural Regeneration Research|April 5, 2020
MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosisBridget Martinez, Philip V Peplow
Neural Regeneration Research|December 17, 2021
MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer's disease and amyotrophic lateral sclerosisBridget Martinez, Philip V Peplow
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Neural Regeneration Research|May 10, 2022
MicroRNAs as biomarkers in glaucoma and potential therapeutic targetsBridget Martinez, Philip V Peplow
Neural Regeneration Research|February 27, 2019
Amelioration of Alzheimer's disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer's diseaseBridget Martinez, Philip V Peplow
Neural Regeneration Research|March 3, 2017
Blood microRNAs as potential diagnostic markers for hemorrhagic strokeBridget Martinez, Philip V Peplow
Physiology (Bethesda, Md.)|February 17, 2017
Thyroid Hormone Regulation and Insulin Resistance: Insights From Animals Naturally Adapted to FastingBridget Martinez, Rudy M Ortiz
Neural Regeneration Research|September 2, 2021
MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approachesBridget Martinez, Philip V Peplow
Neural Regeneration Research|August 6, 2024
MicroRNAs as potential diagnostic biomarkers for bipolar disorderBridget Martinez, Philip V Peplow
Neural Regeneration Research|March 4, 2026
Exosomes and microRNAs in the treatment of in vivo and in vitro models of Parkinson's disease: A narrative literature reviewBridget Martinez, Philip V Peplow
Neural Regeneration Research|August 2, 2017
Immunomodulators and microRNAs as neurorestorative therapy for ischemic strokeBridget Martinez, Philip V Peplow
Neural Regeneration Research|April 5, 2020
MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosisBridget Martinez, Philip V Peplow
Neural Regeneration Research|December 17, 2021
MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer's disease and amyotrophic lateral sclerosisBridget Martinez, Philip V Peplow
Pageof 5